The HECTD1 Knockout HEK293T Polyclonal Cells comprise a CRISPR/Cas9-edited polyclonal knockout cell population designed for functional studies of the HECTD1 gene. This product provides a mixed population of HEK293T cells carrying targeted disruptions in the HECTD1 locus, enabling loss-of-function analysis without clonal selection. The polyclonal format preserves genetic heterogeneity while eliminating target gene expression, offering a robust model for investigating HECTD1-dependent processes.
HEK293T cells are a widely used human embryonic kidney epithelial cell line that stably expresses the SV40 large T antigen. This feature permits episomal replication of plasmids containing the SV40 origin of replication, facilitating high-level recombinant protein expression and lentiviral packaging. The epithelial origin and well-characterized signaling networks of HEK293T cells make them a versatile platform for studying ubiquitin-proteasome system dynamics, Wnt pathway transduction, and protein quality control mechanisms.
HECTD1 encodes an E3 ubiquitin-protein ligase that mediates the ubiquitination and subsequent proteasomal degradation of key substrates, including Hsp90, PIAS1, Dvl2, and ??-catenin. Through these interactions, HECTD1 modulates the Wnt signaling pathway by controlling the stability of ??-catenin and Dishevelled (Dvl2), thereby influencing downstream transcriptional programs. The ligase also interacts with molecular partners such as APC and Axin, integrating signals from Wnt ligands and Frizzled receptors to regulate cell fate, migration, and neural tube closure.
In the HEK293T background, disruption of HECTD1 provides a unique tool to dissect the crosstalk between ubiquitin-mediated proteolysis and Wnt signaling. Because HEK293T cells exhibit robust basal Wnt activity and are amenable to reporter assays, the polyclonal knockout population enables assessment of HECTD1 function in a model that retains epithelial characteristics and efficient transfectability. Researchers can examine how loss of HECTD1 affects the ubiquitination status and turnover of pathway intermediates, offering insights into diseases such as neural tube defects and cancer where HECTD1 dysregulation is implicated. Such investigations are critical for understanding developmental pathologies and tumorigenesis.
Typical research applications include ubiquitination assays to monitor substrate modification, co-immunoprecipitation to map protein interactions, and Wnt reporter assays (e.g., TOPFlash) to quantify pathway activity. Cell migration assays and immunofluorescence localization studies further extend the utility of these cells in neurodevelopment and cancer biology. The polyclonal format ensures a broad representation of knockout events, minimizing clonal artifacts and enhancing reproducibility in functional assays. This polyclonal knockout population supports mechanistic studies of protein quality control and signal transduction. For additional information or technical support, please contact Ascent Research.
